

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cardiac myofibril assembly (GO:0055003) | 9.51052494 |
| 2 | * sarcomere organization (GO:0045214) | 9.47386758 |
| 3 | myofibril assembly (GO:0030239) | 8.30365104 |
| 4 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 8.05804313 |
| 5 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 7.42699449 |
| 6 | cardiac muscle contraction (GO:0060048) | 7.27441910 |
| 7 | * actin-myosin filament sliding (GO:0033275) | 7.03974589 |
| 8 | * muscle filament sliding (GO:0030049) | 7.03974589 |
| 9 | cardiac muscle cell development (GO:0055013) | 6.96923990 |
| 10 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.71168175 |
| 11 | adult heart development (GO:0007512) | 6.70733516 |
| 12 | cardiac cell development (GO:0055006) | 6.55609609 |
| 13 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.38839224 |
| 14 | * cardiac muscle tissue morphogenesis (GO:0055008) | 6.30897760 |
| 15 | regulation of actin filament-based movement (GO:1903115) | 6.29641165 |
| 16 | * ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 6.23553411 |
| 17 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.21401936 |
| 18 | cardiac muscle hypertrophy (GO:0003300) | 6.03210460 |
| 19 | ventricular cardiac muscle cell action potential (GO:0086005) | 6.03182253 |
| 20 | plasma membrane repair (GO:0001778) | 6.02101981 |
| 21 | * actomyosin structure organization (GO:0031032) | 5.98445573 |
| 22 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.95888752 |
| 23 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.91348298 |
| 24 | tricarboxylic acid cycle (GO:0006099) | 5.84552909 |
| 25 | * actin-mediated cell contraction (GO:0070252) | 5.84159771 |
| 26 | regulation of relaxation of muscle (GO:1901077) | 5.82585128 |
| 27 | striated muscle hypertrophy (GO:0014897) | 5.68617696 |
| 28 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.61386168 |
| 29 | * muscle tissue morphogenesis (GO:0060415) | 5.58691367 |
| 30 | regulation of sarcomere organization (GO:0060297) | 5.51814312 |
| 31 | striated muscle contraction (GO:0006941) | 5.46767708 |
| 32 | regulation of the force of heart contraction (GO:0002026) | 5.46436565 |
| 33 | heart trabecula formation (GO:0060347) | 5.46018453 |
| 34 | regulation of cardioblast differentiation (GO:0051890) | 5.40552017 |
| 35 | heart contraction (GO:0060047) | 5.36051281 |
| 36 | heart process (GO:0003015) | 5.36051281 |
| 37 | regulation of skeletal muscle contraction (GO:0014819) | 5.33700402 |
| 38 | detection of calcium ion (GO:0005513) | 5.24667885 |
| 39 | regulation of striated muscle contraction (GO:0006942) | 5.17199052 |
| 40 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.11932143 |
| 41 | muscle hypertrophy (GO:0014896) | 5.04272486 |
| 42 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 5.01877094 |
| 43 | cell communication involved in cardiac conduction (GO:0086065) | 4.87175355 |
| 44 | regulation of membrane repolarization (GO:0060306) | 4.71449386 |
| 45 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.70577101 |
| 46 | striated muscle atrophy (GO:0014891) | 4.67182599 |
| 47 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 4.64264297 |
| 48 | carnitine shuttle (GO:0006853) | 4.63285991 |
| 49 | regulation of cell communication by electrical coupling (GO:0010649) | 4.57676808 |
| 50 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.49428042 |
| 51 | cell communication by electrical coupling (GO:0010644) | 4.40787981 |
| 52 | * actin filament-based movement (GO:0030048) | 4.40639222 |
| 53 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.36031226 |
| 54 | muscle hypertrophy in response to stress (GO:0003299) | 4.36031226 |
| 55 | cardiac muscle adaptation (GO:0014887) | 4.36031226 |
| 56 | regulation of cardiac muscle contraction (GO:0055117) | 4.35806619 |
| 57 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.34354392 |
| 58 | cellular response to epinephrine stimulus (GO:0071872) | 4.32007502 |
| 59 | regulation of heart rate (GO:0002027) | 4.31680489 |
| 60 | negative regulation of protein localization to cell surface (GO:2000009) | 4.28727120 |
| 61 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.28249428 |
| 62 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 4.24868377 |
| 63 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.20831427 |
| 64 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 4.18961636 |
| 65 | muscle atrophy (GO:0014889) | 4.18868545 |
| 66 | cardiac muscle cell action potential (GO:0086001) | 4.15976882 |
| 67 | cardiac chamber formation (GO:0003207) | 4.10308760 |
| 68 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.09689420 |
| 69 | response to epinephrine (GO:0071871) | 4.08306518 |
| 70 | negative regulation of potassium ion transport (GO:0043267) | 4.08117756 |
| 71 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.07900638 |
| 72 | ATP synthesis coupled proton transport (GO:0015986) | 4.07046202 |
| 73 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.07046202 |
| 74 | ventricular cardiac muscle cell development (GO:0055015) | 4.06066826 |
| 75 | striated muscle adaptation (GO:0014888) | 4.03500089 |
| 76 | adrenergic receptor signaling pathway (GO:0071875) | 3.97795436 |
| 77 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.94032692 |
| 78 | fatty acid transmembrane transport (GO:1902001) | 3.92858829 |
| 79 | response to caffeine (GO:0031000) | 3.89271287 |
| 80 | * regulation of heart contraction (GO:0008016) | 3.88551045 |
| 81 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.85115795 |
| 82 | * positive regulation of ATPase activity (GO:0032781) | 3.84525004 |
| 83 | * positive regulation of ATP catabolic process (GO:1903291) | 3.84525004 |
| 84 | * regulation of ATPase activity (GO:0043462) | 3.79995870 |
| 85 | * regulation of ATP catabolic process (GO:1903289) | 3.79995870 |
| 86 | striated muscle cell development (GO:0055002) | 3.79330536 |
| 87 | relaxation of cardiac muscle (GO:0055119) | 3.77731604 |
| 88 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.76610807 |
| 89 | atrial septum morphogenesis (GO:0060413) | 3.75869911 |
| 90 | regulation of cofactor metabolic process (GO:0051193) | 3.74913252 |
| 91 | regulation of coenzyme metabolic process (GO:0051196) | 3.74913252 |
| 92 | muscle system process (GO:0003012) | 3.69986467 |
| 93 | oxygen transport (GO:0015671) | 3.67944769 |
| 94 | regulation of striated muscle cell apoptotic process (GO:0010662) | 3.64752247 |
| 95 | cardiac conduction (GO:0061337) | 3.62402603 |
| 96 | positive regulation of heart contraction (GO:0045823) | 3.62097860 |
| 97 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.59999325 |
| 98 | positive regulation of heart rate (GO:0010460) | 3.59036693 |
| 99 | respiratory electron transport chain (GO:0022904) | 3.58584046 |
| 100 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.57835446 |
| 101 | trabecula formation (GO:0060343) | 3.55145614 |
| 102 | oxidative phosphorylation (GO:0006119) | 3.49699077 |
| 103 | * regulation of muscle system process (GO:0090257) | 3.48001479 |
| 104 | NADH metabolic process (GO:0006734) | 3.47783603 |
| 105 | electron transport chain (GO:0022900) | 3.47667459 |
| 106 | skeletal muscle adaptation (GO:0043501) | 3.46915721 |
| 107 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.45338627 |
| 108 | muscle contraction (GO:0006936) | 3.39933362 |
| 109 | carnitine transmembrane transport (GO:1902603) | 3.38315058 |
| 110 | positive regulation of cation channel activity (GO:2001259) | 3.36098781 |
| 111 | 2-oxoglutarate metabolic process (GO:0006103) | 3.35943976 |
| 112 | positive regulation of action potential (GO:0045760) | 3.35514754 |
| 113 | cardiac ventricle formation (GO:0003211) | 3.35000891 |
| 114 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.34574350 |
| 115 | * regulation of muscle contraction (GO:0006937) | 3.33904561 |
| 116 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.32759360 |
| 117 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.32759360 |
| 118 | cardiac muscle tissue development (GO:0048738) | 3.30817732 |
| 119 | atrioventricular valve morphogenesis (GO:0003181) | 3.29631204 |
| 120 | response to inactivity (GO:0014854) | 3.28977364 |
| 121 | muscle adaptation (GO:0043500) | 3.28289314 |
| 122 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.27669714 |
| 123 | response to redox state (GO:0051775) | 3.23054220 |
| 124 | outflow tract septum morphogenesis (GO:0003148) | 3.18499645 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.10429023 |
| 2 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 5.41504228 |
| 3 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.24860825 |
| 4 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.24860825 |
| 5 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.18964441 |
| 6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.09893745 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.37632033 |
| 8 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.35451263 |
| 9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.21252890 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.03792133 |
| 11 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.93692112 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.79851439 |
| 13 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.70770441 |
| 14 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.61019778 |
| 15 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.15421339 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.12801080 |
| 17 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.11467297 |
| 18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.08291061 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.06378127 |
| 20 | VDR_22108803_ChIP-Seq_LS180_Human | 2.03976192 |
| 21 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.98476746 |
| 22 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.95733512 |
| 23 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.89242739 |
| 24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.83808793 |
| 25 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.79085661 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.69595972 |
| 27 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.69141896 |
| 28 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.67718421 |
| 29 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.62494720 |
| 30 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.62304964 |
| 31 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.58842480 |
| 32 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.55715206 |
| 33 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.50873769 |
| 34 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.50020189 |
| 35 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.48387677 |
| 36 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.46537828 |
| 37 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.44595138 |
| 38 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.43626423 |
| 39 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.41096771 |
| 40 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.39965649 |
| 41 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.37991302 |
| 42 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.37737473 |
| 43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.34056202 |
| 44 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.33431413 |
| 45 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.33185253 |
| 46 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.29884933 |
| 47 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.28982226 |
| 48 | GATA1_19941826_ChIP-Seq_K562_Human | 1.27473007 |
| 49 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.26344582 |
| 50 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.24989612 |
| 51 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.24454346 |
| 52 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.24138867 |
| 53 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.23261139 |
| 54 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.22396383 |
| 55 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.22270139 |
| 56 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.21657441 |
| 57 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.21447411 |
| 58 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21141116 |
| 59 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.20021528 |
| 60 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.19875266 |
| 61 | TP53_16413492_ChIP-PET_HCT116_Human | 1.18735281 |
| 62 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.15066862 |
| 63 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.12363619 |
| 64 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.12193282 |
| 65 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.12090398 |
| 66 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.12090398 |
| 67 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.11087882 |
| 68 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.09191170 |
| 69 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09113882 |
| 70 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.08302255 |
| 71 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.07877611 |
| 72 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.07860204 |
| 73 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07415419 |
| 74 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.07078337 |
| 75 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.06415344 |
| 76 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.05899118 |
| 77 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.05632578 |
| 78 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.05563389 |
| 79 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.04607164 |
| 80 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.04566617 |
| 81 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.04489278 |
| 82 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.02704438 |
| 83 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.02264114 |
| 84 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.01754913 |
| 85 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.01244829 |
| 86 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.00158617 |
| 87 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.99174442 |
| 88 | ATF3_27146783_Chip-Seq_COLON_Human | 0.99000325 |
| 89 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.97417816 |
| 90 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97295998 |
| 91 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97191479 |
| 92 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97063364 |
| 93 | TBL1_22424771_ChIP-Seq_293T_Human | 0.97041197 |
| 94 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.96563035 |
| 95 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.96547321 |
| 96 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.96547321 |
| 97 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96508860 |
| 98 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.95680649 |
| 99 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.95590987 |
| 100 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.95378989 |
| 101 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.95211603 |
| 102 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.94084313 |
| 103 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.93433617 |
| 104 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.92649677 |
| 105 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.92539572 |
| 106 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.92531821 |
| 107 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.92230694 |
| 108 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.92209507 |
| 109 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91006552 |
| 110 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90890399 |
| 111 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.90764089 |
| 112 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.90698127 |
| 113 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.90409354 |
| 114 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.90336071 |
| 115 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.89819640 |
| 116 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89615677 |
| 117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.88046339 |
| 118 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.88024612 |
| 119 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87572663 |
| 120 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.86974389 |
| 121 | SPI1_23127762_ChIP-Seq_K562_Human | 0.86423163 |
| 122 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.86421231 |
| 123 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.85325935 |
| 124 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.84338533 |
| 125 | TCF4_23295773_ChIP-Seq_U87_Human | 0.83974600 |
| 126 | KDM2B_26808549_Chip-Seq_K562_Human | 0.83898359 |
| 127 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.83864197 |
| 128 | * PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.83830738 |
| 129 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83810409 |
| 130 | CJUN_26792858_Chip-Seq_BT549_Human | 0.82887622 |
| 131 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.82697440 |
| 132 | P68_20966046_ChIP-Seq_HELA_Human | 0.82621494 |
| 133 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80269182 |
| 134 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.80110921 |
| 135 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.79297051 |
| 136 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.78667321 |
| 137 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.76890396 |
| 138 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76448413 |
| 139 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.76090129 |
| 140 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.76037607 |
| 141 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.75563139 |
| 142 | GATA1_22025678_ChIP-Seq_K562_Human | 0.75509970 |
| 143 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75288365 |
| 144 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.75275411 |
| 145 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.75233261 |
| 146 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.75137320 |
| 147 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.74957641 |
| 148 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.74605290 |
| 149 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74102033 |
| 150 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73551218 |
| 151 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.72798744 |
| 152 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.72344908 |
| 153 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.71252041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 7.39633525 |
| 2 | MP0004084_abnormal_cardiac_muscle | 6.41224108 |
| 3 | MP0000751_myopathy | 5.06479221 |
| 4 | MP0003646_muscle_fatigue | 5.02812301 |
| 5 | * MP0004215_abnormal_myocardial_fiber | 4.66490477 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.44120318 |
| 7 | MP0005330_cardiomyopathy | 4.15663164 |
| 8 | MP0000749_muscle_degeneration | 3.80646352 |
| 9 | * MP0002972_abnormal_cardiac_muscle | 3.32628767 |
| 10 | * MP0004087_abnormal_muscle_fiber | 3.01106506 |
| 11 | * MP0003137_abnormal_impulse_conducting | 2.94576468 |
| 12 | MP0006138_congestive_heart_failure | 2.73397096 |
| 13 | * MP0005385_cardiovascular_system_phenoty | 2.73172321 |
| 14 | * MP0001544_abnormal_cardiovascular_syste | 2.73172321 |
| 15 | * MP0010630_abnormal_cardiac_muscle | 2.73057438 |
| 16 | MP0000750_abnormal_muscle_regeneration | 2.67990909 |
| 17 | * MP0008775_abnormal_heart_ventricle | 2.66278057 |
| 18 | * MP0005620_abnormal_muscle_contractility | 2.64071379 |
| 19 | MP0003828_pulmonary_edema | 2.61526694 |
| 20 | MP0002106_abnormal_muscle_physiology | 2.39102150 |
| 21 | MP0004484_altered_response_of | 2.33605295 |
| 22 | * MP0004085_abnormal_heartbeat | 2.23693848 |
| 23 | MP0002269_muscular_atrophy | 2.21789149 |
| 24 | MP0004510_myositis | 2.13391432 |
| 25 | MP0004130_abnormal_muscle_cell | 2.05775972 |
| 26 | MP0003221_abnormal_cardiomyocyte_apopto | 2.01055280 |
| 27 | MP0005369_muscle_phenotype | 1.94236145 |
| 28 | MP0002127_abnormal_cardiovascular_syste | 1.89690838 |
| 29 | MP0003950_abnormal_plasma_membrane | 1.83165231 |
| 30 | MP0004145_abnormal_muscle_electrophysio | 1.80939475 |
| 31 | MP0000759_abnormal_skeletal_muscle | 1.77272930 |
| 32 | MP0000747_muscle_weakness | 1.72422825 |
| 33 | MP0004233_abnormal_muscle_weight | 1.67872738 |
| 34 | MP0003567_abnormal_fetal_cardiomyocyte | 1.62337630 |
| 35 | MP0006036_abnormal_mitochondrial_physio | 1.41687912 |
| 36 | MP0003279_aneurysm | 1.36248734 |
| 37 | MP0010368_abnormal_lymphatic_system | 1.32973517 |
| 38 | * MP0000266_abnormal_heart_morphology | 1.22501065 |
| 39 | MP0005666_abnormal_adipose_tissue | 1.19597217 |
| 40 | MP0002332_abnormal_exercise_endurance | 1.18988796 |
| 41 | MP0002234_abnormal_pharynx_morphology | 1.18207927 |
| 42 | MP0005670_abnormal_white_adipose | 1.16456148 |
| 43 | MP0008004_abnormal_stomach_pH | 1.12851073 |
| 44 | MP0000343_altered_response_to | 1.11179189 |
| 45 | MP0005623_abnormal_meninges_morphology | 1.08713560 |
| 46 | MP0005165_increased_susceptibility_to | 1.03366453 |
| 47 | MP0003566_abnormal_cell_adhesion | 0.99959875 |
| 48 | MP0002128_abnormal_blood_circulation | 0.92678114 |
| 49 | MP0005451_abnormal_body_composition | 0.88480580 |
| 50 | MP0004272_abnormal_basement_membrane | 0.85824545 |
| 51 | MP0000767_abnormal_smooth_muscle | 0.83438571 |
| 52 | MP0006035_abnormal_mitochondrial_morpho | 0.83169627 |
| 53 | MP0005375_adipose_tissue_phenotype | 0.80035448 |
| 54 | MP0000230_abnormal_systemic_arterial | 0.79352416 |
| 55 | MP0002108_abnormal_muscle_morphology | 0.79060841 |
| 56 | MP0003705_abnormal_hypodermis_morpholog | 0.78471359 |
| 57 | MP0004185_abnormal_adipocyte_glucose | 0.71320011 |
| 58 | MP0005266_abnormal_metabolism | 0.71311764 |
| 59 | MP0001879_abnormal_lymphatic_vessel | 0.69346883 |
| 60 | MP0001661_extended_life_span | 0.60255823 |
| 61 | MP0008438_abnormal_cutaneous_collagen | 0.59882387 |
| 62 | MP0009384_cardiac_valve_regurgitation | 0.58816593 |
| 63 | * MP0002925_abnormal_cardiovascular_devel | 0.57067930 |
| 64 | MP0002909_abnormal_adrenal_gland | 0.56088190 |
| 65 | MP0000733_abnormal_muscle_development | 0.55694492 |
| 66 | MP0003806_abnormal_nucleotide_metabolis | 0.52519460 |
| 67 | MP0002102_abnormal_ear_morphology | 0.49486321 |
| 68 | * MP0003984_embryonic_growth_retardation | 0.48346523 |
| 69 | * MP0002088_abnormal_embryonic_growth/wei | 0.47337359 |
| 70 | MP0009840_abnormal_foam_cell | 0.46374162 |
| 71 | MP0000003_abnormal_adipose_tissue | 0.45879527 |
| 72 | MP0005187_abnormal_penis_morphology | 0.45681466 |
| 73 | MP0001614_abnormal_blood_vessel | 0.45413784 |
| 74 | * MP0001784_abnormal_fluid_regulation | 0.43688099 |
| 75 | MP0005319_abnormal_enzyme/_coenzyme | 0.41355769 |
| 76 | MP0005503_abnormal_tendon_morphology | 0.38747724 |
| 77 | MP0002254_reproductive_system_inflammat | 0.38020288 |
| 78 | MP0005275_abnormal_skin_tensile | 0.37974234 |
| 79 | MP0003941_abnormal_skin_development | 0.36542498 |
| 80 | MP0004043_abnormal_pH_regulation | 0.36102610 |
| 81 | MP0000013_abnormal_adipose_tissue | 0.35925320 |
| 82 | MP0001299_abnormal_eye_distance/ | 0.34799482 |
| 83 | MP0006072_abnormal_retinal_apoptosis | 0.34643602 |
| 84 | MP0005595_abnormal_vascular_smooth | 0.34549847 |
| 85 | MP0003948_abnormal_gas_homeostasis | 0.33916730 |
| 86 | MP0002971_abnormal_brown_adipose | 0.33157755 |
| 87 | MP0002078_abnormal_glucose_homeostasis | 0.32248891 |
| 88 | MP0001984_abnormal_olfaction | 0.30399452 |
| 89 | MP0005388_respiratory_system_phenotype | 0.28538529 |
| 90 | MP0002133_abnormal_respiratory_system | 0.28538529 |
| 91 | MP0001958_emphysema | 0.27991422 |
| 92 | MP0002295_abnormal_pulmonary_circulatio | 0.27708493 |
| 93 | MP0008961_abnormal_basal_metabolism | 0.27522407 |
| 94 | * MP0001672_abnormal_embryogenesis/_devel | 0.26975573 |
| 95 | * MP0005380_embryogenesis_phenotype | 0.26975573 |
| 96 | MP0000762_abnormal_tongue_morphology | 0.23708931 |
| 97 | MP0000249_abnormal_blood_vessel | 0.22734554 |
| 98 | MP0001727_abnormal_embryo_implantation | 0.22582089 |
| 99 | MP0004147_increased_porphyrin_level | 0.22010999 |
| 100 | MP0002090_abnormal_vision | 0.21474080 |
| 101 | MP0009780_abnormal_chondrocyte_physiolo | 0.21190838 |
| 102 | MP0005167_abnormal_blood-brain_barrier | 0.19562877 |
| 103 | MP0004924_abnormal_behavior | 0.19146511 |
| 104 | MP0005386_behavior/neurological_phenoty | 0.19146511 |
| 105 | MP0008569_lethality_at_weaning | 0.18796368 |
| 106 | MP0004270_analgesia | 0.17921825 |
| 107 | MP0000462_abnormal_digestive_system | 0.17829232 |
| 108 | MP0003935_abnormal_craniofacial_develop | 0.17280555 |
| 109 | MP0005535_abnormal_body_temperature | 0.17091210 |
| 110 | MP0009115_abnormal_fat_cell | 0.16709182 |
| 111 | MP0005253_abnormal_eye_physiology | 0.16703327 |
| 112 | MP0003385_abnormal_body_wall | 0.16316725 |
| 113 | MP0003045_fibrosis | 0.16211980 |
| 114 | MP0005377_hearing/vestibular/ear_phenot | 0.15771420 |
| 115 | MP0001175_abnormal_lung_morphology | 0.15458935 |
| 116 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.14315662 |
| 117 | MP0008874_decreased_physiological_sensi | 0.11871196 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Sudden death (HP:0001699) | 8.51373733 |
| 2 | Ventricular tachycardia (HP:0004756) | 7.61023403 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 6.34971874 |
| 4 | * Atrial fibrillation (HP:0005110) | 6.34222239 |
| 5 | Subaortic stenosis (HP:0001682) | 6.12594302 |
| 6 | Abnormality of the left ventricular outflow tract (HP:0011103) | 6.12594302 |
| 7 | * Primary atrial arrhythmia (HP:0001692) | 5.91655817 |
| 8 | Muscle fiber splitting (HP:0003555) | 5.83972007 |
| 9 | * Lipoatrophy (HP:0100578) | 5.82050666 |
| 10 | * Supraventricular tachycardia (HP:0004755) | 5.71745339 |
| 11 | Abnormality of the calf musculature (HP:0001430) | 5.68314650 |
| 12 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.63517256 |
| 13 | Right ventricular cardiomyopathy (HP:0011663) | 5.61979220 |
| 14 | * Supraventricular arrhythmia (HP:0005115) | 5.61976215 |
| 15 | Exercise-induced muscle cramps (HP:0003710) | 5.47694778 |
| 16 | Syncope (HP:0001279) | 5.28517190 |
| 17 | Exercise-induced myalgia (HP:0003738) | 5.15673618 |
| 18 | Hyporeflexia of lower limbs (HP:0002600) | 5.06423777 |
| 19 | Prolonged QT interval (HP:0001657) | 4.84725246 |
| 20 | * Dilated cardiomyopathy (HP:0001644) | 4.69757871 |
| 21 | Palpitations (HP:0001962) | 4.68928104 |
| 22 | Bundle branch block (HP:0011710) | 4.63271722 |
| 23 | Ventricular arrhythmia (HP:0004308) | 4.53378115 |
| 24 | Asymmetric septal hypertrophy (HP:0001670) | 4.52155459 |
| 25 | EMG: myopathic abnormalities (HP:0003458) | 4.40950314 |
| 26 | Ventricular fibrillation (HP:0001663) | 4.12922336 |
| 27 | Myoglobinuria (HP:0002913) | 4.11227862 |
| 28 | Atrioventricular block (HP:0001678) | 4.02630783 |
| 29 | Heart block (HP:0012722) | 3.99584671 |
| 30 | Abnormal atrioventricular conduction (HP:0005150) | 3.77739792 |
| 31 | Increased connective tissue (HP:0009025) | 3.77215120 |
| 32 | Abnormal EKG (HP:0003115) | 3.49171825 |
| 33 | Myotonia (HP:0002486) | 3.24019076 |
| 34 | Rhabdomyolysis (HP:0003201) | 3.09547149 |
| 35 | Difficulty running (HP:0009046) | 3.07657302 |
| 36 | Aplasia of the musculature (HP:0100854) | 2.95212957 |
| 37 | Popliteal pterygium (HP:0009756) | 2.94496904 |
| 38 | Bradycardia (HP:0001662) | 2.91262806 |
| 39 | Ragged-red muscle fibers (HP:0003200) | 2.89757179 |
| 40 | Difficulty climbing stairs (HP:0003551) | 2.84907605 |
| 41 | * Palmoplantar keratoderma (HP:0000982) | 2.84791737 |
| 42 | Type 2 muscle fiber atrophy (HP:0003554) | 2.80203589 |
| 43 | * Left ventricular hypertrophy (HP:0001712) | 2.77136824 |
| 44 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.73857766 |
| 45 | Acute necrotizing encephalopathy (HP:0006965) | 2.72245704 |
| 46 | Hepatic necrosis (HP:0002605) | 2.70081023 |
| 47 | Rimmed vacuoles (HP:0003805) | 2.52146902 |
| 48 | Muscle fiber atrophy (HP:0100295) | 2.47744377 |
| 49 | Neck muscle weakness (HP:0000467) | 2.47130976 |
| 50 | Ketoacidosis (HP:0001993) | 2.46518480 |
| 51 | Type 1 muscle fiber predominance (HP:0003803) | 2.46097966 |
| 52 | Hypoplastic left heart (HP:0004383) | 2.44071501 |
| 53 | Fatigable weakness (HP:0003473) | 2.43950464 |
| 54 | Abnormality of the neuromuscular junction (HP:0003398) | 2.43950464 |
| 55 | Distal lower limb muscle weakness (HP:0009053) | 2.42283229 |
| 56 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.41079410 |
| 57 | Testicular atrophy (HP:0000029) | 2.40506500 |
| 58 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.39893115 |
| 59 | Abnormality of the foot musculature (HP:0001436) | 2.39407352 |
| 60 | Sudden cardiac death (HP:0001645) | 2.36400016 |
| 61 | Limb-girdle muscle atrophy (HP:0003797) | 2.35524553 |
| 62 | Hepatocellular necrosis (HP:0001404) | 2.35371613 |
| 63 | Congenital malformation of the right heart (HP:0011723) | 2.34745169 |
| 64 | Double outlet right ventricle (HP:0001719) | 2.34745169 |
| 65 | Hypoglycemic coma (HP:0001325) | 2.34041475 |
| 66 | Acute encephalopathy (HP:0006846) | 2.30123290 |
| 67 | Conjunctival hamartoma (HP:0100780) | 2.28321756 |
| 68 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.25421472 |
| 69 | Mitochondrial inheritance (HP:0001427) | 2.22412423 |
| 70 | Increased variability in muscle fiber diameter (HP:0003557) | 2.21486181 |
| 71 | Progressive macrocephaly (HP:0004481) | 2.21090643 |
| 72 | Weak cry (HP:0001612) | 2.14416354 |
| 73 | Muscle fiber inclusion bodies (HP:0100299) | 2.13151681 |
| 74 | Hip contracture (HP:0003273) | 2.13148446 |
| 75 | Areflexia of lower limbs (HP:0002522) | 2.12214755 |
| 76 | EMG: neuropathic changes (HP:0003445) | 2.11616160 |
| 77 | Cerebral edema (HP:0002181) | 2.10366205 |
| 78 | Nemaline bodies (HP:0003798) | 2.08904506 |
| 79 | Pheochromocytoma (HP:0002666) | 2.08878129 |
| 80 | Pulmonary artery stenosis (HP:0004415) | 2.08819680 |
| 81 | Steppage gait (HP:0003376) | 2.08361506 |
| 82 | Increased CSF lactate (HP:0002490) | 2.07695242 |
| 83 | Abnormality of placental membranes (HP:0011409) | 2.07499490 |
| 84 | Amniotic constriction ring (HP:0009775) | 2.07499490 |
| 85 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 2.06925666 |
| 86 | Increased muscle lipid content (HP:0009058) | 2.06535744 |
| 87 | Dysmetric saccades (HP:0000641) | 2.05664293 |
| 88 | Dicarboxylic aciduria (HP:0003215) | 2.05059447 |
| 89 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.05059447 |
| 90 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.04852617 |
| 91 | * Congestive heart failure (HP:0001635) | 2.04533585 |
| 92 | Foot dorsiflexor weakness (HP:0009027) | 2.04337168 |
| 93 | Generalized muscle weakness (HP:0003324) | 2.01978329 |
| 94 | Abnormality of the tricuspid valve (HP:0001702) | 2.00591237 |
| 95 | Hypoplastic heart (HP:0001961) | 2.00440015 |
| 96 | Distal lower limb amyotrophy (HP:0008944) | 2.00297212 |
| 97 | Exercise intolerance (HP:0003546) | 1.97325137 |
| 98 | Neoplasm of the adrenal gland (HP:0100631) | 1.96405453 |
| 99 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.96317919 |
| 100 | Bulbar palsy (HP:0001283) | 1.95802312 |
| 101 | Scapular winging (HP:0003691) | 1.95649582 |
| 102 | Nausea (HP:0002018) | 1.92785800 |
| 103 | Frequent falls (HP:0002359) | 1.92274065 |
| 104 | Easy fatigability (HP:0003388) | 1.90133568 |
| 105 | Muscle stiffness (HP:0003552) | 1.89890535 |
| 106 | Gowers sign (HP:0003391) | 1.89554728 |
| 107 | Muscular dystrophy (HP:0003560) | 1.89450420 |
| 108 | Respiratory failure (HP:0002878) | 1.88563541 |
| 109 | Hamartoma of the eye (HP:0010568) | 1.87778497 |
| 110 | Hypoplastic ischia (HP:0003175) | 1.83930047 |
| 111 | Neuroendocrine neoplasm (HP:0100634) | 1.83292477 |
| 112 | Fetal akinesia sequence (HP:0001989) | 1.82817633 |
| 113 | Lactic acidosis (HP:0003128) | 1.81513629 |
| 114 | Resting tremor (HP:0002322) | 1.81507560 |
| 115 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.81079058 |
| 116 | Increased intramyocellular lipid droplets (HP:0012240) | 1.80483215 |
| 117 | Large for gestational age (HP:0001520) | 1.79419096 |
| 118 | Diaphragmatic weakness (HP:0009113) | 1.78600317 |
| 119 | Patent foramen ovale (HP:0001655) | 1.77963161 |
| 120 | Lymphangioma (HP:0100764) | 1.77444960 |
| 121 | Skin nodule (HP:0200036) | 1.76419149 |
| 122 | Abnormality of the endocardium (HP:0004306) | 1.74973302 |
| 123 | Ketosis (HP:0001946) | 1.74601991 |
| 124 | Generalized aminoaciduria (HP:0002909) | 1.74573189 |
| 125 | Round ear (HP:0100830) | 1.73597931 |
| 126 | Increased serum pyruvate (HP:0003542) | 1.73545792 |
| 127 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.73331256 |
| 128 | Neoplasm of head and neck (HP:0012288) | 1.73308852 |
| 129 | Esophageal neoplasm (HP:0100751) | 1.73308852 |
| 130 | Thin ribs (HP:0000883) | 1.73273835 |
| 131 | Proximal tubulopathy (HP:0000114) | 1.70579809 |
| 132 | Aneurysm (HP:0002617) | 1.69586951 |
| 133 | Renal cortical cysts (HP:0000803) | 1.67619793 |
| 134 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.67444554 |
| 135 | Abnormality of glycolysis (HP:0004366) | 1.59927025 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.42558839 |
| 2 | MYLK | 4.80184713 |
| 3 | LMTK2 | 4.22321678 |
| 4 | OBSCN | 4.18617898 |
| 5 | PHKG2 | 3.59074257 |
| 6 | PHKG1 | 3.59074257 |
| 7 | DMPK | 3.41243702 |
| 8 | PKN2 | 3.34073734 |
| 9 | PDK3 | 2.91575647 |
| 10 | PDK4 | 2.91575647 |
| 11 | PIK3CA | 2.86004564 |
| 12 | TRIB3 | 2.72284092 |
| 13 | MUSK | 2.56084586 |
| 14 | STK24 | 2.48471532 |
| 15 | TIE1 | 2.23165725 |
| 16 | BCKDK | 2.13517729 |
| 17 | NEK1 | 1.99883722 |
| 18 | PAK3 | 1.73156282 |
| 19 | PDK2 | 1.66438562 |
| 20 | CDC42BPA | 1.58655967 |
| 21 | ILK | 1.53213579 |
| 22 | LIMK1 | 1.51980686 |
| 23 | PINK1 | 1.49781511 |
| 24 | PRKD1 | 1.47641205 |
| 25 | CAMK2D | 1.37380053 |
| 26 | ZAK | 1.36856260 |
| 27 | WNK4 | 1.31924645 |
| 28 | ROCK1 | 1.28505529 |
| 29 | STK4 | 1.25754024 |
| 30 | DAPK3 | 1.22139213 |
| 31 | GRK7 | 1.14338862 |
| 32 | RIPK1 | 1.10272672 |
| 33 | STK38L | 1.09074221 |
| 34 | PIK3CG | 1.06261117 |
| 35 | TRPM7 | 0.94949197 |
| 36 | MAPK12 | 0.94416207 |
| 37 | FLT3 | 0.93407654 |
| 38 | MAPKAPK3 | 0.92355433 |
| 39 | MAP3K6 | 0.88459512 |
| 40 | PKN1 | 0.88338657 |
| 41 | MARK1 | 0.87336046 |
| 42 | INSRR | 0.85855974 |
| 43 | PDGFRA | 0.84638997 |
| 44 | PRKAA1 | 0.84159546 |
| 45 | MAP3K7 | 0.83078250 |
| 46 | ROCK2 | 0.81703318 |
| 47 | PTK2B | 0.78855898 |
| 48 | PRKAA2 | 0.77554126 |
| 49 | CCNB1 | 0.72812462 |
| 50 | RPS6KC1 | 0.72165632 |
| 51 | RPS6KL1 | 0.72165632 |
| 52 | WNK1 | 0.72012801 |
| 53 | CAMK4 | 0.71850633 |
| 54 | MAPK4 | 0.71155547 |
| 55 | EPHA3 | 0.70656099 |
| 56 | STK38 | 0.69080219 |
| 57 | TAOK1 | 0.68392730 |
| 58 | KDR | 0.68211950 |
| 59 | DDR2 | 0.66588015 |
| 60 | CAMK2A | 0.63892782 |
| 61 | TGFBR2 | 0.62531631 |
| 62 | RPS6KA6 | 0.61888112 |
| 63 | ICK | 0.60840650 |
| 64 | CAMK1 | 0.59589883 |
| 65 | MAP3K3 | 0.57692582 |
| 66 | EPHB1 | 0.55485522 |
| 67 | PRKACB | 0.55161670 |
| 68 | PRKCE | 0.54784151 |
| 69 | CAMK2B | 0.54707388 |
| 70 | MAP2K3 | 0.51945951 |
| 71 | PLK4 | 0.50703228 |
| 72 | MAP2K1 | 0.45398007 |
| 73 | EPHB2 | 0.44413603 |
| 74 | SIK1 | 0.43874720 |
| 75 | PRKACA | 0.40899196 |
| 76 | PRKACG | 0.40068504 |
| 77 | STK39 | 0.37753128 |
| 78 | PTK6 | 0.36029797 |
| 79 | PRKG2 | 0.34782268 |
| 80 | PRKD3 | 0.34161797 |
| 81 | ITK | 0.33193157 |
| 82 | MAP3K10 | 0.32258597 |
| 83 | MTOR | 0.31306197 |
| 84 | AKT2 | 0.31033144 |
| 85 | PRKCH | 0.31006208 |
| 86 | PDPK1 | 0.29803420 |
| 87 | RAF1 | 0.27531297 |
| 88 | LATS2 | 0.27128780 |
| 89 | FER | 0.26748378 |
| 90 | MAPK10 | 0.25300118 |
| 91 | RPS6KA1 | 0.25035385 |
| 92 | CAMK2G | 0.24928037 |
| 93 | LATS1 | 0.24776600 |
| 94 | PDK1 | 0.21941983 |
| 95 | PRKG1 | 0.21654831 |
| 96 | TGFBR1 | 0.20256528 |
| 97 | ADRBK1 | 0.19380508 |
| 98 | RPS6KA2 | 0.18330275 |
| 99 | PAK2 | 0.17519255 |
| 100 | LRRK2 | 0.17490678 |
| 101 | KSR2 | 0.17331454 |
| 102 | SGK3 | 0.16963841 |
| 103 | STK11 | 0.16128685 |
| 104 | ERBB3 | 0.15606764 |
| 105 | RET | 0.15460247 |
| 106 | NEK9 | 0.15229502 |
| 107 | MAPKAPK2 | 0.15149593 |
| 108 | JAK1 | 0.14823973 |
| 109 | MAPK7 | 0.13991634 |
| 110 | RPS6KA3 | 0.13877470 |
| 111 | SGK2 | 0.13422171 |
| 112 | PRKCD | 0.12751628 |
| 113 | PTK2 | 0.12513303 |
| 114 | PDGFRB | 0.12057426 |
| 115 | PRKD2 | 0.11821383 |
| 116 | UHMK1 | 0.10717745 |
| 117 | SGK1 | 0.09447150 |
| 118 | MARK2 | 0.09166422 |
| 119 | PRKCQ | 0.09123993 |
| 120 | NME2 | 0.05807980 |
| 121 | PAK6 | 0.05330209 |
| 122 | AKT1 | 0.04777118 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.72490314 |
| 2 | * Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.72129708 |
| 3 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.22773366 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.20882931 |
| 5 | * Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.11412790 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 3.25102040 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.24587933 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.13528298 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.85686171 |
| 10 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.68777865 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.60358315 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.35951011 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.35913092 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 2.18307596 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.14021922 |
| 16 | Huntingtons disease_Homo sapiens_hsa05016 | 2.05339979 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.95883174 |
| 18 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.93442484 |
| 19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.91683320 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.64096316 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.34886204 |
| 22 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.22047109 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.15970165 |
| 24 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.14953987 |
| 25 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.14499520 |
| 26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14171208 |
| 27 | Insulin resistance_Homo sapiens_hsa04931 | 1.01051776 |
| 28 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.99190689 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.98200413 |
| 30 | Focal adhesion_Homo sapiens_hsa04510 | 0.90600361 |
| 31 | Lysine degradation_Homo sapiens_hsa00310 | 0.88628043 |
| 32 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86653256 |
| 33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.86624128 |
| 34 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.82019368 |
| 35 | Tight junction_Homo sapiens_hsa04530 | 0.80295810 |
| 36 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.80179207 |
| 37 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.77572234 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.77180604 |
| 39 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.76919545 |
| 40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.73081189 |
| 41 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.69500701 |
| 42 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.68514075 |
| 43 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.67135803 |
| 44 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.66788459 |
| 45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.65501859 |
| 46 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.63860318 |
| 47 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.63722101 |
| 48 | Morphine addiction_Homo sapiens_hsa05032 | 0.63104741 |
| 49 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.58796211 |
| 50 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.58536582 |
| 51 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.57481243 |
| 52 | Adherens junction_Homo sapiens_hsa04520 | 0.55295217 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.55236865 |
| 54 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52216634 |
| 55 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.51777099 |
| 56 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.51706773 |
| 57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50842815 |
| 58 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.49364022 |
| 59 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.49052146 |
| 60 | Amoebiasis_Homo sapiens_hsa05146 | 0.47475059 |
| 61 | Cocaine addiction_Homo sapiens_hsa05030 | 0.46497137 |
| 62 | Mineral absorption_Homo sapiens_hsa04978 | 0.44095570 |
| 63 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43392301 |
| 64 | Renin secretion_Homo sapiens_hsa04924 | 0.42630787 |
| 65 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.42057152 |
| 66 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40823723 |
| 67 | GABAergic synapse_Homo sapiens_hsa04727 | 0.40264794 |
| 68 | Salivary secretion_Homo sapiens_hsa04970 | 0.39282584 |
| 69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38807747 |
| 70 | Insulin secretion_Homo sapiens_hsa04911 | 0.38409019 |
| 71 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.36183441 |
| 72 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.35693900 |
| 73 | Peroxisome_Homo sapiens_hsa04146 | 0.32560965 |
| 74 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.32284925 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32093176 |
| 76 | Circadian entrainment_Homo sapiens_hsa04713 | 0.30514099 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.30390841 |
| 78 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30381403 |
| 79 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.30314977 |
| 80 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.30026505 |
| 81 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.29422238 |
| 82 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.28954406 |
| 83 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.28359173 |
| 84 | Prion diseases_Homo sapiens_hsa05020 | 0.22744840 |
| 85 | Long-term potentiation_Homo sapiens_hsa04720 | 0.22555341 |
| 86 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.20206414 |
| 87 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.20152537 |
| 88 | Metabolic pathways_Homo sapiens_hsa01100 | 0.19102120 |
| 89 | Platelet activation_Homo sapiens_hsa04611 | 0.18863306 |
| 90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.18715014 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.18417708 |
| 92 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.16982468 |
| 93 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.16857493 |
| 94 | Sulfur relay system_Homo sapiens_hsa04122 | 0.16819218 |
| 95 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.16481574 |
| 96 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.16052162 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.15877548 |
| 98 | Olfactory transduction_Homo sapiens_hsa04740 | 0.15816537 |
| 99 | Gap junction_Homo sapiens_hsa04540 | 0.15513150 |
| 100 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.14962884 |
| 101 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.14874141 |
| 102 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.14741930 |
| 103 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.14602835 |
| 104 | Endometrial cancer_Homo sapiens_hsa05213 | 0.13930082 |
| 105 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.13589229 |
| 106 | Circadian rhythm_Homo sapiens_hsa04710 | 0.13582620 |
| 107 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.11274259 |
| 108 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.09580550 |
| 109 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.09116377 |
| 110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.09005137 |
| 111 | Taste transduction_Homo sapiens_hsa04742 | 0.08992899 |
| 112 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.07013615 |
| 113 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.06702681 |
| 114 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.06612613 |
| 115 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.06602082 |
| 116 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.05687171 |
| 117 | Bile secretion_Homo sapiens_hsa04976 | 0.05638393 |
| 118 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.05393315 |
| 119 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.04511206 |
| 120 | Melanogenesis_Homo sapiens_hsa04916 | 0.01228329 |
| 121 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.00781598 |

